| Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition TM Gorges, I Tinhofer, M Drosch, L Röse, TM Zollner, T Krahn, ... BMC cancer 12, 1-13, 2012 | 634 | 2012 |
| Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients Z Liu, A Fusi, E Klopocki, A Schmittel, I Tinhofer, A Nonnenmacher, ... Journal of translational medicine 9, 1-8, 2011 | 228 | 2011 |
| The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN) T Hristozova, R Konschak, C Stromberger, A Fusi, Z Liu, W Weichert, ... Annals of oncology 22 (8), 1878-1885, 2011 | 147 | 2011 |
| Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review V Budach, I Tinhofer The Lancet Oncology 20 (6), e313-e326, 2019 | 146 | 2019 |
| Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalence I Tinhofer, K Jöhrens, U Keilholz, A Kaufmann, A Lehmann, W Weichert, ... European Journal of Cancer 51 (4), 514-521, 2015 | 122 | 2015 |
| Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab–docetaxel treatment I Tinhofer, K Klinghammer, W Weichert, M Knödler, A Stenzinger, T Gauler, ... Clinical Cancer Research 17 (15), 5197-5204, 2011 | 109 | 2011 |
| Patient and treatment-related risk factors for osteoradionecrosis of the jaw in patients with head and neck cancer JD Raguse, J Hossamo, I Tinhofer, B Hoffmeister, V Budach, B Jamil, ... Oral surgery, oral medicine, oral pathology and oral radiology 121 (3), 215 …, 2016 | 103 | 2016 |
| Detection of circulating tumor cells for prediction of recurrence after adjuvant chemoradiation in locally advanced squamous cell carcinoma of the head and neck I Tinhofer, R Konschak, C Stromberger, JD Raguse, JH Dreyer, K Jöhrens, ... Annals of oncology 25 (10), 2042-2047, 2014 | 99 | 2014 |
| Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer E Kidess-Sigal, HE Liu, MM Triboulet, J Che, VC Ramani, BC Visser, ... Oncotarget 7 (51), 85349, 2016 | 93 | 2016 |
| Epithelial–mesenchymal-transition induced by EGFR activation interferes with cell migration and response to irradiation and cetuximab in head and neck cancer cells C Holz, F Niehr, M Boyko, T Hristozova, L Distel, V Budach, I Tinhofer Radiotherapy and oncology 101 (1), 158-164, 2011 | 91 | 2011 |
| Ionizing radiation affects protein composition of exosomes secreted in vitro from head and neck squamous cell carcinoma K Jelonek, A Wojakowska, L Marczak, A Muer, I Tinhofer-Keilholz, ... Acta Biochimica Polonica 62 (2), 265-272, 2015 | 90 | 2015 |
| Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation I Tinhofer, V Budach, M Saki, R Konschak, F Niehr, K Jöhrens, W Weichert, ... European journal of cancer 57, 78-86, 2016 | 87 | 2016 |
| Monitoring of circulating tumor cells and their expression of EGFR/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head … I Tinhofer, T Hristozova, C Stromberger, U KeilhoIz, V Budach International Journal of Radiation Oncology* Biology* Physics 83 (5), e685-e690, 2012 | 80 | 2012 |
| Cancer stem cell characteristics of circulating tumor cells I Tinhofer, M Saki, F Niehr, U Keilholz, V Budach International journal of radiation biology 90 (8), 622-627, 2014 | 79 | 2014 |
| Association of epidermal growth factor receptor polymorphism, skin toxicity, and outcome in patients with squamous cell carcinoma of the head and neck receiving cetuximab … K Klinghammer, M Knödler, A Schmittel, V Budach, U Keilholz, I Tinhofer Clinical Cancer Research 16 (1), 304-310, 2010 | 76 | 2010 |
| MiR-200b and miR-155 as predictive biomarkers for the efficacy of chemoradiation in locally advanced head and neck squamous cell carcinoma AK Hess, A Müer, FD Mairinger, W Weichert, A Stenzinger, M Hummel, ... European Journal of Cancer 77, 3-12, 2017 | 66 | 2017 |
| A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers T Hristozova, R Konschak, V Budach, I Tinhofer Cytometry Part A 81 (6), 489-495, 2012 | 60 | 2012 |
| Multilayered omics-based analysis of a head and neck cancer model of cisplatin resistance reveals intratumoral heterogeneity and treatment-induced clonal selection F Niehr, T Eder, T Pilz, R Konschak, D Treue, F Klauschen, M Bockmayr, ... Clinical Cancer Research 24 (1), 158-168, 2018 | 56 | 2018 |
| A systematic review of the HPV‐attributable fraction of oropharyngeal squamous cell carcinomas in Germany M Reuschenbach, I Tinhofer, C Wittekindt, S Wagner, JP Klussmann Cancer medicine 8 (4), 1908-1918, 2019 | 53 | 2019 |
| Targeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiation I Tinhofer, A Stenzinger, T Eder, R Konschak, F Niehr, V Endris, L Distel, ... Annals of Oncology 27 (12), 2262-2268, 2016 | 50 | 2016 |
